FABBRONI, CHIARA

FABBRONI, CHIARA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma 2021 Sanfilippo R.Casali P. G.Fabbroni C. + Article (author) -
Impact of pathological stratification on the clinical outcomes of advanced well‐differentiated/dedifferentiated liposarcoma treated with trabectedin 2021 Fabbroni C.Ligorio F.Casali P. G.Sanfilippo R. + Article (author) -
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers 2020 Fabbroni, ChiaraManglaviti, SaraFumagalli, ElenaCasali, Paolo GSanfilippo, Roberta + Article (author) -
Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study 2020 Zattarin, EFabbroni, CLigorio, FCorti, CBernocchi, OSirico, MCurigliano, GDe Braud, FGMVernieri, C + Article (author) -
Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors 2020 Sanfilippo, RobertaFabbroni, ChiaraFumagalli, ElenaCasali, Paolo G + Article (author) -
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles 2019 Vernieri, ClaudioPrisciandaro, MicheleMaggi, ClaudiaMennitto, AlessiaFabbroni, ChiaraFarè, Elenade Braud, Filippo + Article (author) -
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 2019 Vernieri, ClaudioMennitto, AlessiaMaggi, ClaudiaPrisciandaro, MicheleFabbroni, Chiarade Braud, Filippo + Article (author) -